This Mobile BSL-2+ cGMP Biocontainment Cleanroom is self-contained on a semi-trailer (420 ft2 / 39 m2 gross area). This facility was designed for the cGMP production of an investigational drug for a novel antibody therapy for treatment of mild to moderate COVID-19 illness. This project was delivered, commissioned, and qualified in Indianapolis, IN within weeks of kick-off to serve the needs of the global pandemic.